Vitavo, formerly known as VaxApp, is an Australian-based Immunisation & Diagnostic Management Platform designed to streamline the delivery of vaccination and health services across various sectors, including community clinics, pharmacies, aged care facilities, workplaces, and schools. Established in 2020, Vitavo has been instrumental in enhancing the efficiency and effectiveness of immunisation programs throughout Australia.
Key Features and Functionality:
- Immunisation Eligibility Engine: Utilises over 30 data points from a client's profile—such as age, medical conditions, and vaccination history—to automate vaccine recommendations, ensuring timely and appropriate immunisations.
- Workflow Automation: Optimises the vaccination process, enabling healthcare providers to administer more vaccines in less time, thereby increasing overall capacity and reducing operational costs.
- Compliance and Reporting: Ensures adherence to mandatory reporting laws by integrating with the Australian Immunisation Register (AIR, facilitating legal compliance and comprehensive data management.
- Inventory Management: Monitors vaccine stock levels to minimise wastage and maintain cold chain compliance, ensuring vaccine efficacy and safety.
- Patient Management: Allows users to create and manage profiles for themselves and their dependents, streamlining appointment scheduling and vaccination tracking.
Primary Value and Solutions Provided:
Vitavo addresses critical challenges in the immunisation sector by automating and optimising the vaccination workflow. By leveraging its advanced eligibility engine and comprehensive management tools, Vitavo enables healthcare providers to:
- Increase Vaccination Capacity: Significantly boost the number of individuals vaccinated within a given timeframe, as demonstrated by a public health service tripling its student vaccinations during a school catch-up program.
- Enhance Operational Efficiency: Reduce the average time required to administer vaccines, exemplified by a workplace health service provider decreasing COVID-19 vaccination times from 6 minutes to 2.01 minutes.
- Improve Patient Outcomes: Facilitate better health outcomes, particularly among minority groups, evidenced by a twofold increase in Meningococcal B vaccine uptake within an indigenous community.
By integrating these features, Vitavo empowers healthcare providers to deliver immunisation services more effectively, ensuring higher coverage rates, improved patient care, and compliance with regulatory requirements.
